Consensus Iqvia Holdings Inc.

Equities

IQV

US46266C1053

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 04:00:02 2024-12-04 pm EST			After market 04:32:17 pm
203.17 ^USD	+1.29%		202.50	-0.33%

03:26pm	HSBC Adjusts Price Target on IQVIA Holdings to $270 From $290	MT
Dec. 02	Nephron Upgrades IQVIA Holdings to Buy, Price Target is $250	MT

Evolution of the Average Target: Iqvia Holdings Inc.

average-target-price-chart IQVIA-HOLDINGS-INC

Evolution of the Target Price: Iqvia Holdings Inc.

target-price-consensus-chart IQVIA-HOLDINGS-INC

Changes in Analyst Recommendations: Iqvia Holdings Inc.

140d4f0b1c10d3e.jlRUosqQ6CUUZg4FbGv7qP9Z84am3zn8p5lYWTgQQYw.4iAhlqC9uBJnD29MDi2M25Fqmfzwr0iX1eApdG1yBsTFGCfyh-e5elxQfQ~e24dd89672fc6a322968979e51881b33

Analysts' recommendations: Iqvia Holdings Inc.

HSBC Adjusts Price Target on IQVIA Holdings to $270 From $290	09:26am	MT
Nephron Upgrades IQVIA Holdings to Buy, Price Target is $250	Dec. 02	MT
Nephron Research Upgrades IQVIA to Buy, Price Target is $250	Dec. 02	MT
Goldman Sachs Adjusts Price Target on IQVIA Holdings to $230 From $250, Maintains Buy Rating	Nov. 26	MT
Redburn Atlantic Adjusts Price Target on IQVIA Holdings to $255 From $276, Maintains Buy Rating	Nov. 25	MT
Baird Adjusts Price Target on IQVIA Holdings to $213 From $223, Maintains Neutral Rating	Nov. 25	MT
Leerink Adjusts Price Target on IQVIA Holdings to $248 From $260, Maintains Outperform Rating	Nov. 19	MT
Argus Cuts Price Target on IQVIA to $260 From $280	Nov. 06	MT
JPMorgan Cuts Price Target on IQVIA to $240 From $279, Maintains Overweight Rating	Nov. 05	MT
UBS Adjusts Price Target on IQVIA to $260 From $300, Maintains Buy Rating	Nov. 01	MT
Citigroup Adjusts Price Target on IQVIA to $225 From $250	Nov. 01	MT
Jefferies Adjusts Price Target on IQVIA to $195 From $242	Nov. 01	MT
BTIG Adjusts Price Target on IQVIA to $260 From $290	Nov. 01	MT
Baird Adjusts Price Target on IQVIA to $223 From $256	Nov. 01	MT
Barclays Adjusts Price Target on IQVIA to $255 From $260	Nov. 01	MT
Goldman Sachs Adjusts Price Target on IQVIA to $250 From $280	Nov. 01	MT
Deutsche Bank Adjusts Price Target on IQVIA to $265 From $270	Nov. 01	MT
Evercore ISI Adjusts Price Target on IQVIA to $235 From $265	Nov. 01	MT
Leerink Partners Adjusts Price Target on IQVIA to $260 From $270	Nov. 01	MT
Stifel Adjusts Price Target on IQVIA to $273 From $312	Nov. 01	MT
TD Cowen Adjusts Price Target on IQVIA to $255 From $270	Nov. 01	MT
Truist Cuts Price Target on IQVIA Holdings to $265 From $286, Maintains Buy Rating	Nov. 01	MT
Analyst recommendations: Amazon.com, Mastercard, Bristol-Myers Squibb Company, Uber Technologies, Regeneron Pharmaceuticals...	Nov. 01
Deutsche Bank Trims Price Target on IQVIA Holdings to $265 From $270, Keeps Buy Rating	Nov. 01	MT
RBC Trims Price Target on IQVIA Holdings to $270 From $275, Keeps Outperform Rating	Oct. 29	MT

More recommendations

Sector Comparison:

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analyst Opinion	4m Revision of opinion	Divergence of analysts' opinions	Divergence of Target Price	Ecart obj. / dr
	IQVIA HOLDINGS INC.					+25.73%
	LONZA GROUP AG					+20.61%
	CELLTRION, INC.					+32.13%
	ICON PUBLIC LIMITED COMPANY					+29.61%
	UNITED THERAPEUTICS CORPORATION					+3.64%
	MODERNA, INC.					+79.46%
	BIO-TECHNE CORPORATION					+13.59%
	MEDPACE HOLDINGS, INC.					+2.55%
	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.					+8.52%
	QIAGEN N.V.					+16.85%
	Average					+23.27%
	Weighted average by Cap.					+25.18%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

200.58USD

Average target price

251.31USD

Spread / Average Target

+25.29%

High Price Target

273.00USD

Spread / Highest target

+36.11%

Low Price Target

195.00USD

Spread / Lowest Target

-2.78%

Analyst Consensus Detail

consensus-detail-chart IQVIA-HOLDINGS-INC

Consensus revision (last 18 months)

consensus-revision-chart IQVIA-HOLDINGS-INC

Analysts covering the company

Nephron Research
Goldman Sachs
Redburn Atlantic
Baird
Leerink Partners
Argus
JPMorgan Chase
UBS
Stifel Nicolaus
Citigroup
Jefferies & Co.
BTIG
Barclays
Deutsche Bank Securities
Evercore ISI
TD Cowen
Truist Securities
RBC Capital Markets
Morgan Stanley
Mizuho Securities
Guggenheim
HSBC
Wells Fargo Securities
Cowen
Credit Suisse
SVB Securities LLC
Piper Sandler
KeyBanc Capital Markets
BofA Securities
Stephens Inc.